SCWorx Corp. (WORX)
NASDAQ: WORX · Real-Time Price · USD
0.2922
-0.0078 (-2.60%)
Sep 9, 2025, 10:04 AM - Market open
SCWorx Revenue
SCWorx had revenue of $682.63K in the quarter ending June 30, 2025, a decrease of -8.00%. This brings the company's revenue in the last twelve months to $2.84M, down -15.79% year-over-year. In the year 2024, SCWorx had annual revenue of $2.99M, down -21.43%.
Revenue (ttm)
$2.84M
Revenue Growth
-15.79%
P/S Ratio
0.25
Revenue / Employee
$405,486
Employees
7
Market Cap
2.30M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.99M | -815.34K | -21.43% |
Dec 31, 2023 | 3.80M | -233.25K | -5.78% |
Dec 31, 2022 | 4.04M | -594.34K | -12.83% |
Dec 31, 2021 | 4.63M | -580.59K | -11.14% |
Dec 31, 2020 | 5.21M | -335.00K | -6.04% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
WORX News
- 5 days ago - SCWorx Corp. Appoints New Chief Technology Officer to Accelerate Innovation in Healthcare Data Solutions - GlobeNewsWire
- 13 days ago - SCWorx Expands Healthcare Data Management Network with New Collaboration - GlobeNewsWire
- 27 days ago - Florida Hospital Selects SCWorx for Data Management for Workday Implementation - GlobeNewsWire
- 9 months ago - SCWorx Reminds Stockholders of Annual Meeting - GlobeNewsWire
- 10 months ago - SCWorx Announces Compliance with Nasdaq's Periodic Reporting Listing Standard - GlobeNewsWire
- 10 months ago - SCWorx Announces Completion of Equity Financing with Institutional Investors - GlobeNewsWire
- 1 year ago - SCWorx Corp. Receives Notice of Non-Compliance from NASDAQ Stock Market Pertaining to its 10-Q for the quarter ended June 30, 2024 - GlobeNewsWire
- 1 year ago - SCWorx Corp. Receives Notice from NASDAQ Stock Market Pertaining to its 10-Q for the quarter ended March 31, 2024 - GlobeNewsWire